Research from Semmelweis University Has Provided New Study Findings on Opioids (Opioid-Based Haptens: Development of Immunotherapy).

A recent study from Semmelweis University in Budapest, Hungary, explores the development of immunotherapy for opioid addiction. The research focuses on the use of vaccines to protect against substance use disorder caused by opioids. The study discusses the design of opioid haptens, the development of the opioid radioimmunoassay, and the results of immunotherapy for opioid use disorders. The research highlights the potential of immunotherapy as a treatment option for opioid addiction. [Extracted from the article]